MedPath

DIAGNOSTIC ROLE OF EUS IN UNEXPLAINED BILIARY DILATATION WITH INCONCLUSIVE CROSS-SECTIONAL IMAGING

Not Applicable
Conditions
Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas
Registration Number
CTRI/2020/07/026695
Lead Sponsor
ANKIT MAHAJA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients referred for evaluation of Biliary ductal dilatation (defined as CBD diameter >7mm on USG , >8mm on CT abdomen and >6mm on MRCP , in those with GB in-situ); and > 10 mm in post-cholecystectomy patients with no definite etiology of CBD dilatation on cross sectional imaging.

Exclusion Criteria

1.The patients who have undergone previous ERCP or surgical CBD exploration.

2.The patients who are not willing to give written consent

3.Patients who are HIV positive

4.Pregnant females

5.Patients with age less than 12 years

6.Unfit for sedation required for EUS examination.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To calculate the diagnostic yield of EUS in patients with dilated CBD with non-diagnostic cross sectional imaging.Timepoint: To calculatete the diagnostic yield of EUS in patients with dilated CBD with non-diagnostic cross sectional imaging.
Secondary Outcome Measures
NameTimeMethod
To calculate the sensitivity and specificity of EUS in correctly diagnosing of the etiology of CBD dilatation on the basis of clinical course and /or need for endoscopic/ radiological/ surgical biliary intervention during 6 months of follow up.Timepoint: 6 MONTHS FOLLOW UP
© Copyright 2025. All Rights Reserved by MedPath